FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for a fixed-dose combination of olanzapine and fluoxetine, enabling generic marketing of the product. The approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Olanzapine and fluoxetine (olanzapine; fluoxetine)

Snippet

SUPPL AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FLUOXETINE)